Skip to content
PubMed This is a summary of 16 peer-reviewed journal articles Updated
Pediatrics

Understanding Your Child's Juvenile Paget Disease Diagnosis

At a Glance

Juvenile Paget disease is an ultra-rare inherited condition that makes a child’s bones remodel too quickly. Bones may become enlarged but weak, leading to bowing, fractures, pain, or short stature; early specialist care may improve mobility and symptoms.

Receiving a diagnosis of Juvenile Paget Disease (JPD) for your child is often an overwhelming experience that begins with more questions than answers. Because this condition is ultra-rare—meaning it affects only a very small number of children worldwide—it is likely that your local pediatrician or family doctor has never encountered it before [1][2].

This page is designed to help you orient yourself to this diagnosis, understand the biology of what is happening in your child’s body, and validate the complex emotions that come with caring for a child with a rare genetic condition.

Understanding the “Rapid Remodeling”

In a healthy body, bone is constantly being broken down and rebuilt in a balanced process. In a child with JPD, this balance is lost. The most common form of the disease is an autosomal recessive inherited disorder, meaning a child inherits a specific genetic change from both parents [2][3].

Most cases are caused by a mutation in the TNFRSF11B gene, which is responsible for producing a protein called osteoprotegerin (OPG) [2]. Think of OPG as a “brake” on the cells that break down bone. Without enough of this protein, the “brake” fails, and the body begins to break down and rebuild bone at an abnormally rapid rate [3][4]. This high-turnover remodeling results in bone that is often larger than normal but much weaker, leading to the characteristic features of the condition [2][1].

Navigating the Diagnosis

Because JPD is so rare, the journey to a diagnosis (sometimes called a “diagnostic odyssey”) can be exhausting and filled with uncertainty [5]. You may have first noticed bowing of the legs, a change in the shape of your child’s skull, or a fracture that seemed to happen too easily [2][1].

One of the primary markers doctors look for is a severely elevated level of alkaline phosphatase (ALP), an enzyme in the blood that signals active bone formation [6][7]. While ALP is naturally higher in growing children, the levels in JPD are typically many times higher than normal, and must be interpreted in the context of age and puberty [6].

Common Fears and Realities

It is completely natural to experience caregiver stress or intense worry about your child’s future [5]. Many parents fear that their child will face constant pain or be unable to walk.

The reality of JPD is that the course of the disease varies significantly from one child to another based on their specific genetic makeup, though a specific variant may not reliably predict an individual child’s course [1][8].

  • Skeletal Impacts: Without treatment, the rapid bone turnover can lead to progressive bowing of the long bones, frequent fractures, and short stature [2][1].
  • Beyond the Bones: Because the genetic change affects the whole body, some children may experience “extra-skeletal” symptoms, such as sensorineural hearing loss (hearing loss caused by changes in the inner ear or nerves) or issues with vision and heart health, though these are not guaranteed [1][8][9].
  • The Power of Early Intervention: While the condition is serious, published cases show that children who receive early, specialized treatment have sometimes experienced significant improvements in bone pain and mobility [10][11]. While favorable outcomes are possible, they are not guaranteed, and treatment responses vary [11].

The Emotional Journey

Caring for a child with an ultra-rare skeletal disorder is an emotional marathon. Research among caregivers in the broader rare-bone-disease community has found high levels of caregiver stress [12].

You may feel:

  • Isolation: The feeling that no one—not even your doctors—quite understands what you are going through [5][13].
  • Helplessness: Watching your child experience pain or physical changes can feel overwhelming [14].
  • Uncertainty: Because the disease is so rare, there is no “standard” roadmap, and treatment is often individualized [15][10].

Finding a community of other “rare” parents, even if their children have different bone conditions, can provide vital emotional support and help you navigate the complexities of the healthcare system [5][16]. You are the expert on your child, and your observations are the most valuable tool your medical team has.

Common questions in this guide

What causes juvenile Paget disease in a child?
Most cases result from an inherited change in the TNFRSF11B gene, with the child receiving a changed copy from both parents. This gene helps make osteoprotegerin, a protein that slows the cells responsible for breaking down bone.
What does a very high alkaline phosphatase level mean in juvenile Paget disease?
Alkaline phosphatase is a blood enzyme that reflects bone-building activity. Children normally have higher levels while growing, but levels in juvenile Paget disease can be many times higher and must be judged according to the child's age and pubertal stage.
What symptoms can juvenile Paget disease cause?
Children may develop bowing of the legs, changes in skull shape, bone pain, fractures, or short stature because their bones are being remodeled too quickly. Some children also have hearing loss, vision problems, or heart-related concerns, but these effects do not occur in every child.
Can early treatment improve a child's juvenile Paget disease?
Published cases suggest that early, specialized treatment may improve bone pain and mobility in some children. The disease course and treatment response vary, so improvement cannot be guaranteed.
Why should a child with juvenile Paget disease see a bone specialist?
Juvenile Paget disease is extremely rare, so many local clinicians may not have treated it before. A pediatric bone specialist or rare disease team can help interpret genetic and blood-test results, assess bone health, and plan individualized monitoring and care.

Get notified when new evidence is published on Juvenile Paget disease.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (16)
  1. 1

    Juvenile Paget disease.

    Polyzos SA, Cundy T, Mantzoros CS

    Metabolism: clinical and experimental 2018; (80()):15-26 doi:10.1016/j.metabol.2017.10.007.

    PMID: 29080812
  2. 2

    Juvenile Paget's Disease From Heterozygous Mutation of SP7 Encoding Osterix (Specificity Protein 7, Transcription Factor SP7).

    Whyte MP, Campeau PM, McAlister WH, et al.

    Bone 2020; (137()):115364 doi:10.1016/j.bone.2020.115364.

    PMID: 32298837
  3. 3

    Genetic disorders associated with the RANKL/OPG/RANK pathway.

    Xue JY, Ikegawa S, Guo L

    Journal of bone and mineral metabolism 2021; (39(1)):45-53 doi:10.1007/s00774-020-01148-4.

    PMID: 32940787
  4. 4

    Auricular ossification: A newly recognized feature of osteoprotegerin-deficiency juvenile Paget disease.

    Gottesman GS, Madson KL, McAlister WH, et al.

    American journal of medical genetics. Part A 2016; (170A(4)):978-85 doi:10.1002/ajmg.a.37536.

    PMID: 26762549
  5. 5

    Ultra-rare ultra-care: Assessing the impact of caring for children with ultra rare diseases.

    Domaradzki J, Walkowiak D

    European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society 2024; (48()):78-84 doi:10.1016/j.ejpn.2023.12.003.

    PMID: 38071849
  6. 6

    Alkaline phosphatase in paediatric practice: a practical approach with a proposed diagnostic algorithm.

    Parys J, Nowicki JK, Jakubowska-Pietkiewicz E

    Journal of pediatric endocrinology & metabolism : JPEM 2026; doi:10.1515/jpem-2026-0400.

    PMID: 42867915
  7. 7

    The first neonatal case of Juvenile Paget disease with homozygous deletion in the TNFRSF11B gene.

    Yarci E, Turen B, Ozturk Yarci D, et al.

    Journal of pediatric endocrinology & metabolism : JPEM 2026; (39(10)):1060-1065 doi:10.1515/jpem-2026-0056.

    PMID: 42112796
  8. 8

    Loss of Functional Osteoprotegerin: More Than a Skeletal Problem.

    Grasemann C, Unger N, Hövel M, et al.

    The Journal of clinical endocrinology and metabolism 2017; (102(1)):210-219 doi:10.1210/jc.2016-2905.

    PMID: 27809640
  9. 9

    Juvenile Paget's disease with compound heterozygous mutations in TNFRSF11B presenting with recurrent clavicular fractures and a mild skeletal phenotype.

    Naot D, Wilson LC, Allgrove J, et al.

    Bone 2020; (130()):115098 doi:10.1016/j.bone.2019.115098.

    PMID: 31655221
  10. 10

    Clinical course in two children with Juvenile Paget's disease during long-term treatment with intravenous bisphosphonates.

    Höppner J, Steff K, Misof BM, et al.

    Bone reports 2021; (14()):100762 doi:10.1016/j.bonr.2021.100762.

    PMID: 33850973
  11. 11

    Juvenile Paget's Disease: Report of a successful treatment throughout the complete growth of a patient with a missense TNFRSF11B mutation.

    Prata AR, Saraiva J, Salgado M, Estanqueiro P

    Joint bone spine 2021; (88(6)):105243 doi:10.1016/j.jbspin.2021.105243.

    PMID: 34166796
  12. 12

    Prevalence of depression and anxiety, and their relationship to social support among patients and family caregivers of rare bone diseases.

    Lai X, Jiang Y, Sun Y, et al.

    Orphanet journal of rare diseases 2023; (18(1)):18 doi:10.1186/s13023-022-02611-3.

    PMID: 36703212
  13. 13

    Improving care pathways for people living with rare bone diseases (RBDs): outcomes from the first RBD Summit.

    Chandran M, Alves I, Carpenter T, et al.

    Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 2023; (34(8)):1301-1310 doi:10.1007/s00198-023-06791-x.

    PMID: 37294334
  14. 14

    "Why them, why me, why us?" The experiences of parents of children with lysosomal acid lipase deficiency: an interpretative phenomenological analysis study.

    Hassall S, Smith DM, Rust S, et al.

    Orphanet journal of rare diseases 2022; (17(1)):193 doi:10.1186/s13023-022-02335-4.

    PMID: 35550173
  15. 15

    Osteogenesis imperfecta and the family: A qualitative analysis of the experiences of family and caregivers.

    Colombo GM, Wiese AD, Mercado AE, et al.

    Families, systems & health : the journal of collaborative family healthcare 2025; (43(3)):482-499 doi:10.1037/fsh0001004.

    PMID: 40638332
  16. 16

    Facebook as a Lifeboat: An Interview Study Exploring the Role of Facebook in Supporting Parents of Children with Rare Diseases.

    Victor B, Yilmaz NG, Hoving C, et al.

    Journal of health communication 2026; 1-13 doi:10.1080/10810730.2026.2723703.

    PMID: 42687858

This page explains juvenile Paget disease for informational purposes only and does not constitute medical advice. Your child's pediatric bone specialist and medical team can interpret laboratory and genetic results and recommend care for your child.